Location Paris, Ile-de-France, France Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Thomas has over 25 years’ experience in neuroscience, both in clinical residency and within the industry. Thomas joined Coave from Orphazyme A/S where he served as Chief Medical Officer until November 2021. At Orphazyme A/S he was responsible for devising the clinical development strategy and progressing the company’s rare
neurodegenerative pipeline, while also contributing to both IPOs on the Copenhagen and Nasdaq stock exchanges. Thomas has also held global leadership roles within the clinical neuroscience divisions at both Roche and Bristol Myers Squibb, with a further neuroscience translational medicine role at Novartis.
